Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00013143 · ClinicalTrials.gov registry record · NA
Patient Profiling and Provider Feedback to Reduce Adverse Drug Events
A NA study of Adverse Drug Events, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
- 1
- Study location
NCT00013143: Completed NA study of Adverse Drug Events, sponsored by US Department of Veterans Affairs.
NCT00013143 is a NA study of Adverse Drug Events that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,200 participants, above the 589-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (104% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00013143, a NA study of Adverse Drug Events, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
Adverse drug events (ADE) present a unique focus for error reduction. Computerized provider order entry, with embedded clinical decision support, has great promise in reducing medication errors but preventable adverse drug events may still occur despite such systems.
Conditions Studied
Interventions
- BEHAVIORAL Patient risk profiling (potential ADEs) w/provider feedback
Study Locations (1)
California
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2001-06 |
| Est. Completion | 2003-01 |
| Phase | NA |
What the finished NCT00013143 record still lists
NCT00013143 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 589-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (104% higher).
The record links to 1 condition, with Adverse Drug Events appearing as the primary indexed condition, and to 1 intervention - of which Patient risk profiling (potential ADEs) w/provider feedback is the first listed.
NCT00013143 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00013143 about?
NCT00013143 is a clinical study titled "Patient Profiling and Provider Feedback to Reduce Adverse Drug Events". Adverse drug events (ADE) present a unique focus for error reduction. Computerized provider order entry, with embedded clinical decision support, has great promise in reducing medication errors but preventable adverse drug events may still occur despite such systems.
What is the current status of trial NCT00013143?
This trial is currently completed. It is a NA study. The enrollment target is 1,200 participants. The study started on 2001-06. Estimated completion is 2003-01.
What conditions does trial NCT00013143 study?
This clinical trial studies the following conditions: Adverse Drug Events.
What interventions are being tested in trial NCT00013143?
The interventions under investigation include: Patient risk profiling (potential ADEs) w/provider feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT00013143?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00013143 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Drug Events
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Multi-Center Medication Reconciliation Quality Improvement Study
COMPLETED · NA
-
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
COMPLETED · NA
-
Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
COMPLETED · NA
-
Improving Safety by Basic Computerizing Outpatient Prescribing
COMPLETED · Phase 2
-
Response to Medication Registry
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia